These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31107984)

  • 1. Pregnancy and delivery in women with von Willebrand disease.
    Castaman G; James PD
    Eur J Haematol; 2019 Aug; 103(2):73-79. PubMed ID: 31107984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease.
    Castaman G
    Mediterr J Hematol Infect Dis; 2013; 5(1):e2013052. PubMed ID: 23936623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate.
    Iorio A; James P; Ma A; Srivastava A
    J Thromb Haemost; 2024 Oct; 22(10):2739-2744. PubMed ID: 38950781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
    Federici AB; Castaman G; Mannucci PM;
    Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment.
    Pacheco LD; Costantine MM; Saade GR; Mucowski S; Hankins GD; Sciscione AC
    Am J Obstet Gynecol; 2010 Sep; 203(3):194-200. PubMed ID: 20417473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C; Miesbach W
    Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience.
    Lubetsky A; Martinowitz U; Luboshitz J; Kenet G; Keller N; Tamarin I; Inbal A
    Haemophilia; 2002 Sep; 8(5):622-8. PubMed ID: 12199669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand disease: pathogenesis and management.
    Rodeghiero F
    Thromb Res; 2013 Jan; 131 Suppl 1():S47-50. PubMed ID: 23452742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand disease.
    James AH
    Obstet Gynecol Surv; 2006 Feb; 61(2):136-45. PubMed ID: 16433937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand disease in pregnancy.
    Lipe BC; Dumas MA; Ornstein DL
    Hematol Oncol Clin North Am; 2011 Apr; 25(2):335-58, viii. PubMed ID: 21444034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
    Peyvandi F; Kouides P; Turecek PL; Dow E; Berntorp E
    Blood Rev; 2019 Nov; 38():100572. PubMed ID: 31229334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
    Rodeghiero F; Castaman G; Tosetto A
    Hematology Am Soc Hematol Educ Program; 2009; ():113-23. PubMed ID: 20008189
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.